PubMed · 1992 · 20 citations · 0 references
MedicinePharmacologyBiochemical PharmacologyHemostasisMolecular PharmacologyAnticoagulant TherapyEndothelial ActivationEndothelial Regulation Of HemostasisFibrin FormationHemostatic AgentsThrombin GenerationEndothelial Anticoagulant FunctionEndothelial Fibrinolytic ActivityEndothelial Regulation Of CoagulationFibrinolytic RegulationMechanisms Of Clot LysisPlasminogen Activator ReleasePlasminogen ActivatorsThrombomodulin Signaling
Cultured confluent human umbilical vein endothelial cells were incubated with new-breviscapine (NB), a flavonoid consisting of 4-OH-scutellarin-7-O-glucuronide (C33H30O18) and FeCl3, MgCl2, and CaCl2, which is first extracted from Erigeron breviscapus (Vant) Hand-Mazz in China, 0, 6.25, 12.5, 25, 50, 100, and 1,000 micrograms.ml-1. The releases of tissue-type plasminogen activator (t-PA), and epoprostenol (Epo) from endothelial cells were stimulated by NB, but no significant effect of plasminogen activator inhibitor (PAI) activity was seen. NB 25-1,000 micrograms.ml-1 induced a production of thrombomodulin (TM) within the cells, an expression of TM on the surface of the cells, and a release of TM from the cells. Our data provide a new evidence that NB is a stimulant to fibrinolysis and anticoagulation of endothelial cells.